BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research

Experience Developing, Seeking Regulatory Approval of and Commercializing Multi-Billion Dollar Neurology Therapies NEW YORK, May 27, 2020 -- (Healthcare Sales & Marketing Network) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer... Regenerative Medicine, Neurology, Personnel BrainStorm Cell Therapeutics, NurOwn, stem cell

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2046043

Source: HSMN NewsFeed - May 27, 2020 Category: Pharmaceuticals Source Type: news